News

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach? Medical experts weigh in.
(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...
Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...
Although new medicines can help you lose weight faster and healthier than ever, a new psychology is needed to keep your ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 ...
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
GLP-1 medications have an impressive history of weight loss, but there are options to consider. For example, one study on the oral medication Qsymia found people lost up to 11% of their body ...